These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 35891800)

  • 1. Role of Antimicrobial Peptides in Treatment and Prevention of Mycobacterium Tuberculosis: A Review.
    Mehta K; Sharma P; Mujawar S; Vyas A
    Int J Pept Res Ther; 2022; 28(5):132. PubMed ID: 35891800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host Antimicrobial Peptides: The Promise of New Treatment Strategies against Tuberculosis.
    Arranz-Trullén J; Lu L; Pulido D; Bhakta S; Boix E
    Front Immunol; 2017; 8():1499. PubMed ID: 29163551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial peptides as novel anti-tuberculosis therapeutics.
    Silva JP; Appelberg R; Gama FM
    Biotechnol Adv; 2016; 34(5):924-940. PubMed ID: 27235189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic amphipathic D-enantiomeric antimicrobial peptides with in vitro and ex vivo activity against drug-resistant Mycobacterium tuberculosis.
    Lan Y; Lam JT; Siu GK; Yam WC; Mason AJ; Lam JK
    Tuberculosis (Edinb); 2014 Dec; 94(6):678-89. PubMed ID: 25154927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taming the Devil: Antimicrobial Peptides for Safer TB Therapeutics.
    Jadhav K; Singh R; Ray E; Singh AK; Verma RK
    Curr Protein Pept Sci; 2022; 23(10):643-656. PubMed ID: 35619262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial Peptides: An Emerging Category of Therapeutic Agents.
    Mahlapuu M; Håkansson J; Ringstad L; Björn C
    Front Cell Infect Microbiol; 2016; 6():194. PubMed ID: 28083516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial peptides and proteins in mycobacterial therapy: current status and future prospects.
    Padhi A; Sengupta M; Sengupta S; Roehm KH; Sonawane A
    Tuberculosis (Edinb); 2014 Jul; 94(4):363-73. PubMed ID: 24813349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between antimicrobial peptides and mycobacteria.
    Gutsmann T
    Biochim Biophys Acta; 2016 May; 1858(5):1034-43. PubMed ID: 26851776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial Peptides: A Promising Strategy for Anti-tuberculosis Therapeutics.
    Ning Y; Wang L; Wang M; Meng X; Qiao J
    Protein Pept Lett; 2023; 30(4):280-294. PubMed ID: 36924097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance.
    Nuti R; Goud NS; Saraswati AP; Alvala R; Alvala M
    Curr Med Chem; 2017; 24(38):4303-4314. PubMed ID: 28814242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
    Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
    Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host-Directed Therapy as a Novel Treatment Strategy to Overcome Tuberculosis: Targeting Immune Modulation.
    Ahmed S; Raqib R; Guðmundsson GH; Bergman P; Agerberth B; Rekha RS
    Antibiotics (Basel); 2020 Jan; 9(1):. PubMed ID: 31936156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In pursuit of next-generation therapeutics: Antimicrobial peptides against superbugs, their sources, mechanism of action, nanotechnology-based delivery, and clinical applications.
    Thakur A; Sharma A; Alajangi HK; Jaiswal PK; Lim YB; Singh G; Barnwal RP
    Int J Biol Macromol; 2022 Oct; 218():135-156. PubMed ID: 35868409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of 12 antimicrobial peptides against Mycobacterium tuberculosis and Mycobacterium avium clinical isolates.
    Portell-Buj E; Vergara A; Alejo I; López-Gavín A; Monté MR; San Nicolás L; González-Martín J; Tudó G
    J Med Microbiol; 2019 Feb; 68(2):211-215. PubMed ID: 30570475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very Short and Stable Lactoferricin-Derived Antimicrobial Peptides: Design Principles and Potential Uses.
    Svendsen JSM; Grant TM; Rennison D; Brimble MA; Svenson J
    Acc Chem Res; 2019 Mar; 52(3):749-759. PubMed ID: 30829472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug-resistant infections.
    Zhu Y; Hao W; Wang X; Ouyang J; Deng X; Yu H; Wang Y
    Med Res Rev; 2022 Jul; 42(4):1377-1422. PubMed ID: 34984699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human antimicrobial peptides in ocular surface defense.
    Mohammed I; Said DG; Dua HS
    Prog Retin Eye Res; 2017 Nov; 61():1-22. PubMed ID: 28587935
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.